The potential for Big Data in Type 2 diabetes

Hyer SL1*, Chang J2, Chuah LL3, Manzoor R4 and Philip N5

Type 2 diabetes is a chronic condition associated with long term complications and premature death. It is a leading cause of non-traumatic amputations, renal failure and blindness. With advances in information technology, diabetes patient data are increasingly collated digitally, however, there is no unifi ed minimal dataset agreed nationally or internationally for data collection. A huge amount of data including patient data, pathology reports, and prescription information is generated by health providers and this information collectively is known as “Big Data.” The Aegle project, A European Union Horizon 2020 funded study, looks at the issue of gathering Big Data, with the aim of harnessing it to help develop personalised therapy to patients with the aim of improving health and optimise outcomes. In this paper, we highlight the potential of the Aegle Project to harness Big Data with real data examples. At the clinical decision support user interface, we show examples where predictive analysis helps stratify patients into risk categories for complications and for therapeutic responses. At the research-oriented user interface, we show how the implementation of this integrated data system has already revealed novel associations that could form the basis for future clinical studies.

Keywords:

Published on: Jul 8, 2019 Pages: 39-42

Full Text PDF Full Text HTML DOI: 10.17352/2455-5479.000051
CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat